University of Missouri, PhD in Genetics
University of Science and Technology, BS in Biology
Executive role in China public pharma and responsible for new drug discovery and R&D, including IND Enabling and clinical PoC CMC/cGMP planning and license, BD and commercialisation etc.
Gloria Pharma (SZ: 002437), Chief Scientist, BoD Director, R&D VP
Biotreatment Department Head, Chief Researcher, Genetic Institute of Novartis Research Foundation
Post-Doc researcher, Susan G. Komen Breast Cancer Foudation, UCSD
nvolved in several license in/out projects, transaction size 800M USD